1. Home
  2. ETNB vs TMP Comparison

ETNB vs TMP Comparison

Compare ETNB & TMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • TMP
  • Stock Information
  • Founded
  • ETNB 2018
  • TMP 1836
  • Country
  • ETNB United States
  • TMP United States
  • Employees
  • ETNB N/A
  • TMP N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • TMP Major Banks
  • Sector
  • ETNB Health Care
  • TMP Finance
  • Exchange
  • ETNB Nasdaq
  • TMP Nasdaq
  • Market Cap
  • ETNB 1.0B
  • TMP 893.3M
  • IPO Year
  • ETNB 2019
  • TMP N/A
  • Fundamental
  • Price
  • ETNB $7.70
  • TMP $61.81
  • Analyst Decision
  • ETNB Strong Buy
  • TMP Buy
  • Analyst Count
  • ETNB 9
  • TMP 2
  • Target Price
  • ETNB $27.25
  • TMP $69.00
  • AVG Volume (30 Days)
  • ETNB 1.5M
  • TMP 45.0K
  • Earning Date
  • ETNB 05-01-2025
  • TMP 04-25-2025
  • Dividend Yield
  • ETNB N/A
  • TMP 4.04%
  • EPS Growth
  • ETNB N/A
  • TMP 653.03
  • EPS
  • ETNB N/A
  • TMP 5.16
  • Revenue
  • ETNB N/A
  • TMP $297,067,000.00
  • Revenue This Year
  • ETNB N/A
  • TMP $12.86
  • Revenue Next Year
  • ETNB N/A
  • TMP $7.68
  • P/E Ratio
  • ETNB N/A
  • TMP $11.91
  • Revenue Growth
  • ETNB N/A
  • TMP 35.84
  • 52 Week Low
  • ETNB $4.16
  • TMP $43.32
  • 52 Week High
  • ETNB $11.84
  • TMP $79.01
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 53.47
  • TMP 55.86
  • Support Level
  • ETNB $7.40
  • TMP $60.24
  • Resistance Level
  • ETNB $8.92
  • TMP $62.82
  • Average True Range (ATR)
  • ETNB 0.54
  • TMP 1.71
  • MACD
  • ETNB 0.13
  • TMP 0.59
  • Stochastic Oscillator
  • ETNB 53.88
  • TMP 86.24

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.

Share on Social Networks: